Related Experiment Video
Updated: Mar 1, 2026

07:25
CRISPR-Cas9-Mediated Genome Editing in the Filamentous Ascomycete Huntiella omanensis
Published on: June 9, 2020
10.2K
A CRISPR Cas9 high-throughput genome editing toolkit for kinetoplastids
Tom Beneke1, Ross Madden1, Laura Makin1
1Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
Royal Society Open Science
|June 3, 2017
Summary
This study introduces a CRISPR-Cas9 toolkit for rapid gene editing in kinetoplastids, enabling high-throughput creation of mutant phenotypes for pathogen research.
Area of Science:
- Molecular Biology
- Genetics
- Parasitology
Background:
- Kinetoplastids are significant pathogens requiring advanced genetic manipulation tools.
- Current methods for generating kinetoplastid mutants are often time-consuming and labor-intensive.
- CRISPR-Cas9 technology offers a promising avenue for efficient genetic engineering.
Purpose of the Study:
- To develop a user-friendly CRISPR-Cas9 toolkit for rapid gene tagging and knockout in kinetoplastids.
- To create scalable methods for high-throughput generation of mutant kinetoplastid phenotypes.
- To facilitate functional studies and localization screening of kinetoplastid proteins.
Main Methods:
- Development of a CRISPR-Cas9 toolkit requiring no DNA cloning.
- Implementation of single-guide RNA delivery via PCR-generated DNA templates and T7 RNA polymerase.
- Utilizing an online resource (LeishGEdit.net) for automated primer design.
- Creation of plasmids for rapid DNA construct generation and transfection.
Main Results:
- Successful knock-in of various tags (fluorescent proteins, BirA*, luciferase, HaloTag, epitope tags) at N- or C-termini.
- Generation of null mutants in *Leishmania major*, *Leishmania mexicana*, and *Trypanosoma brucei* in a single transfection round.
- Undetectable deleted genes in non-clonal populations, demonstrating high efficiency.
- Establishment of rapid and large-scale knockout screening capabilities.
Conclusions:
- The developed CRISPR-Cas9 toolkit significantly accelerates genetic manipulation in kinetoplastids.
- This technology enables high-throughput functional genomics and drug target validation in these pathogens.
- The toolkit provides a scalable and efficient platform for diverse kinetoplastid species.
Related Concept Videos
CRISPR/Cas9 Genome Editing
2.2K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.2K
CRISPR
58.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.3K
CRISPR and crRNAs
19.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.4K
Homologous Recombination
64.4K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
64.4K

